bpc-157 safety evidence clinical trials and the Difference Between an Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
Schedule: Daily subcutaneous injections for a 68 week loading phase, then maintenance dosing about 1 weekly (or as needed) [3]
Athletes Managing Chronic Overuse Issues: CrossFit athletes, runners, cyclists, tennis players, and individuals in high-volume training programs frequently develop chronic tendon and ligament issues from repetitive stress
One-way ANOVA was performed for data that met the homogeneity of variance, and post hoc comparisons were corrected by the Bonferroni method
Some peptide breakdown products retain partial activity while others become inactive
